News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Huge study could lead to genetic screening for prostate cancer
Genetic screening for prostate cancer is now a real possibility following results from the largest-ever study into inherited risk factors for the disease. A clinical trial is likely to start this year as a result of the findings.
Luke Johnson is appointed Chairman of the ICR
Leading entrepreneur and former Chairman of Channel 4 will take the helm at the UK’s top academic research centre in August.
Cancer Research Technology and The Institute of Cancer Research enter collaboration with Janssen to discover multiple myeloma drug
A collaboration between the ICR, Cancer Research Technology and Janssen Biotech will seek to discover new multiple myeloma drugs by targeting a key protein on a cell-signalling route called the unfolded protein response (UPR) pathway.
Gene fault has domino effect on cancer risk
A team at the ICR have found some cancer patients inherit a weak point in their DNA that appears to leave one of their chromosomes vulnerable to damage.
Scientists unlock hidden potential of cutting-edge cancer drugs
A class of cutting-edge cancer drugs could keep patients alive for much longer than they do now following a major new discovery about exactly how they attack tumours.
Awards for ICR researchers, Maria and Vicky
Vicky Bull, PhD student, was awarded the ‘BMUS Young Investigator's Award’ and Dr Maria Vinci, Post Doc Training Fellow, is nominated for a SET for BRITAIN Award.
A new way to overcome breast cancer drug resistance
Scientists at the ICR have discovered a potential new way to overcome the resistance many women develop towards a treatment for breast cancer.
New insights into molecular mechanism of childhood cancer
A molecule's key role in the development of a childhood cancer has been discovered by scientists at The Institute of Cancer Research, London.
.jpg?sfvrsn=c51c15c8_2 "Professor Kevin Harrington (Jon Enoch for the ICR, 2012)")
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses
Professor Kevin Harrington has just been appointed joint head of the division of radiotherapy and imaging at The Institute of Cancer Research (ICR), London. Here, he talks about the novel approach his department will be taking to traditional radiotherapy treatment.
Gene may explain why some breast cancers are hard to treat
Researchers have identified a gene which some aggressive breast cancers rely on to survive, helping to explain why certain patients fail to benefit from targeted treatment.
Plan for action to fight global cancer unveiled
A 10-point plan to turn back the tide on cancer has been published to mark World Cancer Day. Developed by the World Oncology Forum, including the ICR's Professor Stan Kaye, the plan calls for more focus on research, and for governments around the world to invest in better healthcare systems to help reduce the number of people dying from the disease.
New Tumour Profiling Unit signals push for personalised cancer treatment
A new Tumour Profiling Unit at the ICR will accelerate the development of personalised cancer treatments and their delivery to patients.
